Baxter International Inc.

Baxter International Inc. is an American multinational healthcare company headquartered in Deerfield, Illinois, dedicated to saving and sustaining lives. Founded in 1931, the company develops, manufactures, and commercializes a broad portfolio of essential healthcare products and digital health solutions globally.

The company's key offerings span three primary business segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. These include sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, and advanced surgical equipment. Baxter's products are utilized across various healthcare settings, such as hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and for patient care at home.

Under the leadership of CEO Andrew Hider, Baxter International maintains a top-five global ranking in its core markets. The company has undergone strategic restructuring, including the divestment of its Kidney Care business unit (Vantive) in August 2024 and the sale of its biopharma solutions business in May 2023, to focus on higher-growth areas like hospital solutions and connected care. Recent innovations include the introduction of the IV Verify Line Labeling System in March 2026, aimed at improving IV labeling in healthcare settings.